JAZZ logo

Jazz Pharmaceuticals plc (JAZZ) Working capital

annual working capital:

$3.59B+$1.86B(+107.87%)
December 31, 2024

Summary

  • As of today (September 1, 2025), JAZZ annual working capital is $3.59 billion, with the most recent change of +$1.86 billion (+107.87%) on December 31, 2024.
  • During the last 3 years, JAZZ annual working capital has risen by +$1.84 billion (+104.80%).
  • JAZZ annual working capital is now at all-time high.

Performance

JAZZ Working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZbalance sheet metrics

quarterly working capital:

$1.28B-$1.63B(-55.97%)
June 30, 2025

Summary

  • As of today (September 1, 2025), JAZZ quarterly working capital is $1.28 billion, with the most recent change of -$1.63 billion (-55.97%) on June 30, 2025.
  • Over the past year, JAZZ quarterly working capital has dropped by -$660.67 million (-34.06%).
  • JAZZ quarterly working capital is now -64.37% below its all-time high of $3.59 billion, reached on December 31, 2024.

Performance

JAZZ quarterly working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZbalance sheet metrics

Working capital Formula

Working Capital = Current Assets − Current Liabilities

JAZZ Working capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+107.9%-34.1%
3 y3 years+104.8%-23.9%
5 y5 years+183.7%-32.4%

JAZZ Working capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+127.0%-64.4%at low
5 y5-yearat high+183.7%-64.4%at low
alltimeall timeat high+2872.7%-64.4%+1033.8%

JAZZ Working capital History

DateAnnualQuarterly
Jun 2025
-
$1.28B(-56.0%)
Mar 2025
-
$2.91B(-19.1%)
Dec 2024
$3.59B(+107.9%)
$3.59B(+6.8%)
Sep 2024
-
$3.36B(+73.2%)
Jun 2024
-
$1.94B(+7.8%)
Mar 2024
-
$1.80B(+4.2%)
Dec 2023
$1.73B(+9.2%)
$1.73B(+3.7%)
Sep 2023
-
$1.67B(-19.0%)
Jun 2023
-
$2.06B(+21.9%)
Mar 2023
-
$1.69B(+6.7%)
Dec 2022
$1.58B(-9.8%)
$1.58B(+1.8%)
Sep 2022
-
$1.55B(-7.5%)
Jun 2022
-
$1.68B(+7.8%)
Mar 2022
-
$1.56B(-11.1%)
Dec 2021
$1.75B(-19.8%)
$1.75B(+2.6%)
Sep 2021
-
$1.71B(-10.6%)
Jun 2021
-
$1.91B(-20.8%)
Mar 2021
-
$2.41B(+10.5%)
Dec 2020
$2.19B(+72.7%)
$2.19B(+14.2%)
Sep 2020
-
$1.91B(+1.1%)
Jun 2020
-
$1.89B(+68.7%)
Mar 2020
-
$1.12B(-11.4%)
Dec 2019
$1.27B(+42.5%)
$1.27B(+12.0%)
Sep 2019
-
$1.13B(+12.9%)
Jun 2019
-
$1.00B(+12.2%)
Mar 2019
-
$891.62M(+0.3%)
Dec 2018
$888.52M(+31.8%)
$888.52M(-20.9%)
Sep 2018
-
$1.12B(+17.1%)
Jun 2018
-
$958.98M(+27.7%)
Mar 2018
-
$750.70M(+11.3%)
Dec 2017
$674.33M(+37.4%)
$674.33M(+19.8%)
Sep 2017
-
$562.77M(+36.6%)
Jun 2017
-
$412.11M(+14.4%)
Mar 2017
-
$360.08M(-26.6%)
Dec 2016
$490.66M(-52.4%)
$490.66M(-4.0%)
Sep 2016
-
$511.37M(-49.1%)
Jun 2016
-
$1.00B(+15.2%)
Mar 2016
-
$871.79M(-15.4%)
DateAnnualQuarterly
Dec 2015
$1.03B(+29.0%)
$1.03B(+5.8%)
Sep 2015
-
$974.75M(-4.4%)
Jun 2015
-
$1.02B(+15.6%)
Mar 2015
-
$882.35M(+10.4%)
Dec 2014
$799.04M(+21.0%)
$799.04M(+22.0%)
Sep 2014
-
$654.78M(+88.6%)
Jun 2014
-
$347.14M(+24.3%)
Mar 2014
-
$279.31M(-57.7%)
Dec 2013
$660.59M(+83.5%)
$660.59M(+8.9%)
Sep 2013
-
$606.71M(+10.3%)
Jun 2013
-
$549.83M(+36.2%)
Mar 2013
-
$403.65M(+12.1%)
Dec 2012
$360.03M(+146.2%)
$360.03M(+74.4%)
Sep 2012
-
$206.44M(+90.9%)
Jun 2012
-
$108.12M(-51.4%)
Mar 2012
-
$222.56M(+52.2%)
Dec 2011
$146.26M(+907.2%)
$146.26M(+54.6%)
Sep 2011
-
$94.61M(+72.7%)
Jun 2011
-
$54.77M(+64.0%)
Mar 2011
-
$33.40M(+130.0%)
Dec 2010
$14.52M(-165.2%)
$14.52M(-209.2%)
Sep 2010
-
-$13.30M(-45.0%)
Jun 2010
-
-$24.20M(-22.4%)
Mar 2010
-
-$31.17M(+39.9%)
Dec 2009
-$22.29M(-82.8%)
-$22.29M(+148.6%)
Sep 2009
-
-$8.97M(-48.7%)
Jun 2009
-
-$17.48M(-87.2%)
Mar 2009
-
-$136.99M(+5.8%)
Dec 2008
-$129.49M(-263.4%)
-$129.49M(-4067.3%)
Sep 2008
-
$3.26M(-3150.5%)
Jun 2008
-
-$107.00K(-100.2%)
Mar 2008
-
$44.52M(-43.8%)
Dec 2007
$79.23M(+29.8%)
$79.23M(-30.3%)
Sep 2007
-
$113.62M(-12.3%)
Jun 2007
-
$129.53M(+177.5%)
Mar 2007
-
$46.67M(-23.5%)
Dec 2006
$61.04M(+658.5%)
$61.04M(+658.5%)
Dec 2005
$8.05M
$8.05M

FAQ

  • What is Jazz Pharmaceuticals plc annual working capital?
  • What is the all time high annual working capital for Jazz Pharmaceuticals plc?
  • What is Jazz Pharmaceuticals plc annual working capital year-on-year change?
  • What is Jazz Pharmaceuticals plc quarterly working capital?
  • What is the all time high quarterly working capital for Jazz Pharmaceuticals plc?
  • What is Jazz Pharmaceuticals plc quarterly working capital year-on-year change?

What is Jazz Pharmaceuticals plc annual working capital?

The current annual working capital of JAZZ is $3.59B

What is the all time high annual working capital for Jazz Pharmaceuticals plc?

Jazz Pharmaceuticals plc all-time high annual working capital is $3.59B

What is Jazz Pharmaceuticals plc annual working capital year-on-year change?

Over the past year, JAZZ annual working capital has changed by +$1.86B (+107.87%)

What is Jazz Pharmaceuticals plc quarterly working capital?

The current quarterly working capital of JAZZ is $1.28B

What is the all time high quarterly working capital for Jazz Pharmaceuticals plc?

Jazz Pharmaceuticals plc all-time high quarterly working capital is $3.59B

What is Jazz Pharmaceuticals plc quarterly working capital year-on-year change?

Over the past year, JAZZ quarterly working capital has changed by -$660.67M (-34.06%)
On this page